Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02293174 · ClinicalTrials.gov registry record

Retinal Fundus Camera Evaluation

A clinical trial, sponsored by Topcon Medical Systems.

Completed
Registry status
10
Enrollment target

NCT02293174: Completed study, sponsored by Topcon Medical Systems.

NCT02293174 is a clinical trial that has completed, run by Topcon Medical Systems. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02293174 has completed, sponsored by Topcon Medical Systems.

COMPLETED
Registry status
10 participants
Enrollment target

Study Summary

Establish a normal baseline setting configuration for image capture using the Topcon TRC-NW400 non-mydriatic retinal camera.

Primary Outcome

Determining the best display to reflect the real color of the retina

Interventions

  • DEVICE Topcon TRC-NW400
  • DEVICE TRC-NW8
  • DEVICE TRC-NW400
  • DEVICE Canon-CR2
  • DEVICE Zeiss Visucam PRO

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2014-09
Est. Completion 2015-01
Topcon Medical Systems

24 total trials

What the finished NCT02293174 record still lists

NCT02293174 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.

The record links to 0 conditions, and to 5 interventions - of which Topcon TRC-NW400 is the first listed.

NCT02293174 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02293174 about?

NCT02293174 is a clinical study titled "Retinal Fundus Camera Evaluation". Establish a normal baseline setting configuration for image capture using the Topcon TRC-NW400 non-mydriatic retinal camera.

What is the current status of trial NCT02293174?

This trial is currently completed. The enrollment target is 10 participants. The study started on 2014-09. Estimated completion is 2015-01.

What interventions are being tested in trial NCT02293174?

The interventions under investigation include: Topcon TRC-NW400 (DEVICE), TRC-NW8 (DEVICE), TRC-NW400 (DEVICE), Canon-CR2 (DEVICE), Zeiss Visucam PRO (DEVICE).

Who is sponsoring clinical trial NCT02293174?

This trial is sponsored by Topcon Medical Systems, which has 24 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02293174, the US trial registry maintained by the National Library of Medicine. NCT02293174 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.